Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
gave a dose of Kinrix to a patient who was 7 years and 4 months old as their 4th DTaP and 4th Polio vaccine.; gave a dose of Kinrix to a patient who was 7 years and 4 months old as their 4th DTaP and 4th Polio vaccine.; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate age at vaccine administration in a 7-year-old male patient who received DTPa-IPV (Kinrix) for prophylaxis. On an unknown date, the patient received Kinrix (unknown arm). On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: gave a dose of Kinrix to a patient who was 7 years and 4 months old as their 4th DTaP and 4th Polio vaccine.) and inappropriate schedule of vaccine administered (Verbatim: gave a dose of Kinrix to a patient who was 7 years and 4 months old as their 4th DTaP and 4th Polio vaccine.). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-SEP-2025 The medical assistant administered a dose of Kinrix to a patient who was 7 years and 4 months old, as their fourth dose of DTaP and fourth dose of Polio vaccine. The state registry had listed Kinrix as the suggested vaccine for that visit.